166 related articles for article (PubMed ID: 25746324)
21. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle.
Qiu GH; Salto-Tellez M; Ross JA; Yeo W; Cui Y; Wheelhouse N; Chen GG; Harrison D; Lai P; Tao Q; Hooi SC
J Hepatol; 2008 Mar; 48(3):433-41. PubMed ID: 18191269
[TBL] [Abstract][Full Text] [Related]
22. Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma.
Weiss D; Stockmann C; Schrödter K; Rudack C
Cell Oncol (Dordr); 2013 Jun; 36(3):213-24. PubMed ID: 23529585
[TBL] [Abstract][Full Text] [Related]
23. Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage.
Zhang Q; Ying J; Li J; Fan Y; Poon FF; Ng KM; Tao Q; Jin J
J Urol; 2010 Aug; 184(2):731-7. PubMed ID: 20639048
[TBL] [Abstract][Full Text] [Related]
24. Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.
Peyser ND; Freilino M; Wang L; Zeng Y; Li H; Johnson DE; Grandis JR
Oncogene; 2016 Mar; 35(9):1163-9. PubMed ID: 25982282
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
26. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
[TBL] [Abstract][Full Text] [Related]
28. Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma.
Zuo C; Zhang H; Spencer HJ; Vural E; Suen JY; Schichman SA; Smoller BR; Kokoska MS; Fan CY
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):484-90. PubMed ID: 19786217
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis.
Youssef EM; Lotan D; Issa JP; Wakasa K; Fan YH; Mao L; Hassan K; Feng L; Lee JJ; Lippman SM; Hong WK; Lotan R
Clin Cancer Res; 2004 Mar; 10(5):1733-42. PubMed ID: 15014026
[TBL] [Abstract][Full Text] [Related]
30. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
[TBL] [Abstract][Full Text] [Related]
31. Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas.
Li L; Xu J; Qiu G; Ying J; Du Z; Xiang T; Wong KY; Srivastava G; Zhu XF; Mok TS; Chan AT; Chan FK; Ambinder RF; Tao Q
Theranostics; 2018; 8(1):61-77. PubMed ID: 29290793
[No Abstract] [Full Text] [Related]
32. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
Zuo C; Ai L; Ratliff P; Suen JY; Hanna E; Brent TP; Fan CY
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):967-75. PubMed ID: 15184253
[TBL] [Abstract][Full Text] [Related]
33. Methylation of DLEC1 promoter is a predictor for recurrence in Chinese patients with gastric cancer.
Ye X; Feng G; Jiao N; Pu C; Zhao G; Sun G
Dis Markers; 2014; 2014():804023. PubMed ID: 25574068
[TBL] [Abstract][Full Text] [Related]
34. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
[TBL] [Abstract][Full Text] [Related]
36. Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
Szaumkessel M; Wojciechowska S; Janiszewska J; Zemke N; Byzia E; Kiwerska K; Kostrzewska-Poczekaj M; Ustaszewski A; Jarmuz-Szymczak M; Grenman R; Wierzbicka M; Bartochowska A; Szyfter K; Giefing M
Tumour Biol; 2017 Mar; 39(3):1010428317691427. PubMed ID: 28345455
[TBL] [Abstract][Full Text] [Related]
37. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
Brieger J; Pongsapich W; Mann SA; Hedrich J; Fruth K; Pogozelski B; Mann WJ
Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134
[TBL] [Abstract][Full Text] [Related]
38. Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma.
Alsofyani AA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Elaimi A; Al-Qahtani MH; Abuzenadah AM; Dallol A
J Appl Genet; 2017 Nov; 58(4):459-465. PubMed ID: 28812223
[TBL] [Abstract][Full Text] [Related]
39. PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas.
Bertonha FB; Barros Filho Mde C; Kuasne H; Dos Reis PP; da Costa Prando E; Muñoz JJ; Roffé M; Hajj GN; Kowalski LP; Rainho CA; Rogatto SR
Mol Oncol; 2015 Feb; 9(2):450-62. PubMed ID: 25454821
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
